Radiotherapy and Oncology

1

Does IGRT ensure target dose coverage of head and neck IMRT patients?

Pierre Graff, Weigang Hu, Sue S. Yom, Jean Pouliot

Journal:

Year:

2012

Language:

english

File:

PDF, 546 KB

english, 2012

2

Stereotactic body radiation therapy in the treatment of multiple primary lung cancers

Kimberly M. Creach, Jeffrey D. Bradley, Pawinee Mahasittiwat, Clifford G. Robinson

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 207 KB

english, 2012

3

Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy

Kimberly M. Creach, Issam El Naqa, Jeffrey D. Bradley, Jeffrey R. Olsen, Parag J. Parikh, Robert E. Drzymala, Charles Bloch, Clifford G. Robinson

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 272 KB

english, 2012

4

The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer

Wouter van Elmpt, Dirk De Ruysscher, Anke van der Salm, Annemarie Lakeman, Judith van der Stoep, Daisy Emans, Eugène Damen, Michel Öllers, Jan-Jakob Sonke, José Belderbos

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 241 KB

english, 2012

5

Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans

Martin Stuschke, Andreas Kaiser, Christoph Pöttgen, Wolfgang Lübcke, Jonathan Farr

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 487 KB

english, 2012

6

An analysis of patient positioning during stereotactic lung radiotherapy performed without rigid external immobilization

Max Dahele, Wilko Verbakel, Johan Cuijpers, Ben Slotman, Suresh Senan

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 456 KB

english, 2012

7

Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas

Gianluisa Sicignano, Marco Losa, Antonella del Vecchio, Giovanni Mauro Cattaneo, Piero Picozzi, Angelo Bolognesi, Pietro Mortini, Riccardo Calandrino

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 204 KB

english, 2012

8

[18F]-FDG uptake dose–response correlates with radiation pneumonitis in lung cancer patients

Matthew R. McCurdy, Richard Castillo, Josue Martinez, Mohammad Najeeb Al Hallack, Jessica Lichter, Nicolas Zouain, Thomas Guerrero

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 274 KB

english, 2012

9

A comparison of tumor motion characteristics between early stage and locally advanced stage lung cancers

Z. Henry Yu, Steven H. Lin, Peter Balter, Lifei Zhang, Lei Dong

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 706 KB

english, 2012

10

Incidence of isolated nodal failure in non-small cell lung cancer patients included in a prospective study of the value of PET–CT

Milena Kolodziejczyk, Krzysztof Bujko, Wojciech Michalski, Lucyna Kepka

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 157 KB

english, 2012

11

Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer

Andre Konski, Tianyu Li, Michael Christensen, Jonathan D. Cheng, Jian Q. Yu, Kevin Crawford, Oleh Haluszka, Jeffrey Tokar, Walter Scott, Neal J. Meropol, Steven J. Cohen, Alan Maurer, Gary M. Freedman

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 179 KB

english, 2012

12

Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?

Katy Clarke, Mojgan Taremi, Max Dahele, Marc Freeman, Sharon Fung, Kevin Franks, Andrea Bezjak, Anthony Brade, John Cho, Andrew Hope, Alexander Sun

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 280 KB

english, 2012

13

Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancer

John A. Vargo, Dwight E. Heron, Robert L. Ferris, Jean-Claude M. Rwigema, Rodney E. Wegner, Ronny Kalash, James Ohr, Greg J. Kubicek, Steven Burton

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 404 KB

english, 2012

14

FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status

Maximilian Niyazi, Oliver Schnell, Bogdana Suchorska, Silke Birgit Schwarz, Ute Ganswindt, Julia Geisler, Peter Bartenstein, Friedrich-Wilhelm Kreth, Jörg-Christian Tonn, Sabina Eigenbrod, Claus Belka

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 302 KB

english, 2012

15

Use of fractional dose–volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06

Susan L. Tucker, Jeff M. Michalski, Walter R. Bosch, Radhe Mohan, Lei Dong, Kathryn Winter, James A. Purdy, James D. Cox

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 285 KB

english, 2012

16

The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone

Margriet G.A. Sattler, André P. van Beek, Bruce H.R. Wolffenbuttel, Gerrit van den Berg, Wim J. Sluiter, Johannes A. Langendijk, Alphons C.M. van den Bergh

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 263 KB

english, 2012

17

Relationship between irradiated breast volume and late normal tissue complications: A systematic review

Mukesh Mukesh, Emma Harris, Raj Jena, Philip Evans, Charlotte Coles

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 232 KB

english, 2012

18

The effect of short term neo-adjuvant androgen deprivation on erectile function in patients treated with external beam radiotherapy for localised prostate cancer: An analysis of the 4- versus 8-month randomised trial (Irish Clinical Oncology Research Group 97-01)

Patricia E. Daly, Mary T. Dunne, Carmel M. O’Shea, Marie A. Finn, John G. Armstrong

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 273 KB

english, 2012

19

Circulating regulatory T cells of cancer patients receiving radiochemotherapy may be useful to individualize cancer treatment

Manuel A. Schmidt, Claudia Förtsch, Manfred Schmidt, Tilman T. Rau, Rainer Fietkau, Luitpold V. Distel

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 994 KB

english, 2012

20

Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab – Pooled results from two prospective clinical trials

Andreas Hallqvist, Bengt Bergman, Jan Nyman

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 212 KB

english, 2012

21

Late gastrointestinal and urogenital side-effects after radiotherapy – Incidence and prevalence. Subgroup-analysis within the prospective Austrian–German phase II multicenter trial for localized prostate cancer

Maximilian P. Schmid, Richard Pötter, Valentin Bombosch, Samir Sljivic, Christian Kirisits, Wolfgang Dörr, Gregor Goldner

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 555 KB

english, 2012

22

Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters

Edy Ippolito, Francesco Deodato, Gabriella Macchia, Mariangela Massaccesi, Cinzia Digesù, Giuseppe A. Pirozzi, Gianluca Spera, Stefania Marangi, Emanuele Annoscia, Savino Cilla, Angelo Piermattei, Vin

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 284 KB

english, 2012

23

Editorial Board

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 23 KB

english, 2012

24

Important ESTRO dates

Journal:

Radiotherapy and Oncology

Year:

2012

File:

PDF, 486 KB

2012

26

Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: Potential relevance for MRI-guided localized therapy

Annemarie C. Schmitz, Kenneth E. Pengel, Claudette E. Loo, Maurice A.A.J. van den Bosch, Jelle Wesseling, Maria Gertenbach, Tanja Alderliesten, Willem P.Th.M. Mali, Emiel J. Th. Rutgers, Harry Barteli

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 402 KB

english, 2012

27

Editorial Board

Journal:

Radiotherapy and Oncology

Year:

2012

Language:

english

File:

PDF, 33 KB

english, 2012

Volume 104; Issue 1

Does IGRT ensure target dose coverage of head and neck IMRT patients?

Stereotactic body radiation therapy in the treatment of multiple primary lung cancers

Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy

The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer

Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans

An analysis of patient positioning during stereotactic lung radiotherapy performed without rigid external immobilization

Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas

[18F]-FDG uptake dose–response correlates with radiation pneumonitis in lung cancer patients

A comparison of tumor motion characteristics between early stage and locally advanced stage lung cancers

Incidence of isolated nodal failure in non-small cell lung cancer patients included in a prospective study of the value of PET–CT

Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer

Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?

Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancer

FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status

Use of fractional dose–volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06

The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone

Relationship between irradiated breast volume and late normal tissue complications: A systematic review

The effect of short term neo-adjuvant androgen deprivation on erectile function in patients treated with external beam radiotherapy for localised prostate cancer: An analysis of the 4- versus 8-month randomised trial (Irish Clinical Oncology Research Group 97-01)

Circulating regulatory T cells of cancer patients receiving radiochemotherapy may be useful to individualize cancer treatment

Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab – Pooled results from two prospective clinical trials

Late gastrointestinal and urogenital side-effects after radiotherapy – Incidence and prevalence. Subgroup-analysis within the prospective Austrian–German phase II multicenter trial for localized prostate cancer

Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters

Editorial Board

Contents

Important ESTRO dates

Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: Potential relevance for MRI-guided localized therapy

Editorial Board